Preoperative concurrent paclitaxel, carboplatin and radiotherapy in advanced operable cancer of the oropharynx and oral cavity: A phase II evaluation

被引：0
|
作者：
Eckhardt, A
Wildfang, I
Karstens, JH
机构：
[1] Hannover Med Univ, Dept Oral & Maxillofacial Surg, Hannover, Germany
[2] Hannover Med Univ, Dept Radiat Oncol, Hannover, Germany
来源：
EUROPEAN JOURNAL OF CANCER | 1999年 / 35卷
关键词：
D O I：
10.1016/S0959-8049(99)81088-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
660
引用
收藏
页码：S174 / S174
页数：1
相关论文
共 50 条
  • [31] TREATMENT RESULTS WITH COMBINED PREOPERATIVE RADIOTHERAPY AND SURGERY FOR CARCINOMAS OF THE ORAL CAVITY AND OROPHARYNX
    KNOBBER, D
    LUCKHAUPT, H
    ROSE, KG
    ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 1986, 243 (01): : 66 - 66
  • [32] Neoadjuvant paclitaxel, carboplatin and concurrent weekly paclitaxel and conventional radiotherapy for locally advanced NSCLC.
    Yöney, A
    Kandemir, Ö
    Akbörü, H
    Altin, S
    Ünsal, M
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 706S - 706S
  • [33] Concurrent Radiotherapy, Paclitaxel and Dose Escalating Carboplatin in the Treatment of Cervical Cancer - A Phase I Study
    Addeo, Daniela
    Blank, Stephanie
    Muggia, Franco
    Formenti, Silvia
    ANTICANCER RESEARCH, 2008, 28 (5B) : 3143 - 3146
  • [34] A phase III study of concurrent radiotherapy with carboplatin of weekly paclitaxel in patients with advanced squamous cell head and neck cancer (SCHNC)
    Andreadis, C
    Sidiropoulos, J
    Vahtsevanos, K
    Thomaidis, J
    Destouni, E
    Kasfikis, D
    Mouratidou, D
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S172 - S172
  • [35] Phase II trial of preoperative capecitabine with concurrent radiotherapy in patients with locally advanced rectal cancer.
    Arias, F.
    de las Heras, M.
    del Moral, R.
    Gomez Millan, J.
    Jimenez, E.
    Wals, A.
    Alcantara, P.
    RADIOTHERAPY AND ONCOLOGY, 2006, 81 : S132 - S133
  • [36] Phase II evaluation of paclitaxel in combination with carboplatin in advanced head and neck carcinoma
    Clark, JI
    Hofmeister, C
    Choudhury, A
    Matz, G
    Collins, S
    Bastian, R
    Melian, E
    Emami, B
    Petruzzelli, G
    CANCER, 2001, 92 (09) : 2334 - 2340
  • [37] Preoperative radiochemotherapy of advanced resectable cancer of the oral cavity with cisplatin vs paclitaxel/carboplatin. Analysis of two multimodality treatment concepts
    Eckardt, A.
    Wegener, G.
    Karstens, J. H.
    ORAL AND MAXILLOFACIAL SURGERY-HEIDELBERG, 2006, 10 (01): : 30 - 36
  • [38] Phase II trial of paclitaxel and carboplatin in advanced/metastatic transitional cell cancer
    Wille, AH
    Johannsen, M
    Roigas, J
    Schnorr, DR
    JOURNAL OF UROLOGY, 2003, 169 (04): : 380 - 381
  • [39] A phase II study of frontline paclitaxel/carboplatin/bevacizumab, paclitaxel/carboplatin/temsirolimus, or ixabepilone/carboplatin/bevacizumab in advanced/recurrent endometrial cancer
    Aghajanian, Carol
    Filiaci, Virginia
    Dizon, Don S.
    Carlson, Jay W.
    Powell, Matthew A.
    Secord, Angeles Alvarez
    Tewari, Krishnansu S.
    Bender, David P.
    O'Malley, David M.
    Stuckey, Ashley
    Gao, Jianjiong
    Dao, Fanny
    Soslow, Robert A.
    Lankes, Heather A.
    Moore, Kathleen
    Levine, Douglas A.
    GYNECOLOGIC ONCOLOGY, 2018, 150 (02) : 274 - 281
  • [40] Phase I/II study of carboplatin plus nab-paclitaxel and concurrent radiotherapy for patients with locally advanced non-small cell lung cancer
    Kawano, Yuko
    Sasaki, Tomonari
    Yamaguchi, Hiroyuki
    Hirano, Katsuya
    Horiike, Atsushi
    Satouchi, Miyako
    Hosokawa, Shinobu
    Morinaga, Ryotaro
    Komiya, Kazutoshi
    Inoue, Koji
    Fujita, Yuka
    Toyozawa, Ryo
    Kimura, Tomoki
    Takahashi, Kosuke
    Nishikawa, Kazuo
    Kishimoto, Junji
    Nakanishi, Yoichi
    Okamoto, Isamu
    LUNG CANCER, 2018, 125 : 136 - 141
12345